EVERSANA is a proud sponsor of the World Patient Safety Congress Europe, September 22-24 in Amsterdam, and the World Patient Safety Congress Americas, October 13-15 in Boston. Stop by our booth at WPSC Europe (Booth #518) or WPSC Americas (Booth #339) to explore how EVERSANA delivers flexible, integrated pharmacovigilance solutions, purpose-built for you.
A New Approach to Commercial Compliance Excellence
EVERSANA’s integrated commercial compliance solutions in life sciences combine pharmacovigilance, regulatory, medical, and quality processes into a single, coordinated model to ensure global compliance, improve visibility, and reduce operational risk.
What We Deliver
- Pharmacovigilance and drug safety operations
- Global regulatory compliance and submissions
- Medical review and information governance
- Risk management and audit readiness
Why It Matters
As regulatory complexity increases, fragmented compliance models create risk. An integrated approach ensures consistency, visibility, and scalability across regions.
Speaking Session
Hear from Dr. Vivek Ahuja, Executive Vice President of Compliance, Pharmacovigilance Live at WPSC Europe
- Purpose-Built Pharmacovigilance: Why Modern Drug Safety Demands More Than Traditional PV
- Tuesday, September 22 at 15:00 | Workshop 1
Most pharmacovigilance systems were built for large pharmaceutical companies and later repurposed for everyone else. But what works for global pharma often leads to compromise for first-time approvals, emerging biotechs, cell and gene therapy developers, biosimilar manufacturers, or consumer health and cosmetovigilance companies.
The difference between success and failure often lies in overlooked design decisions. This session uncovers the principles that determine whether pharmacovigilance merely functions or becomes a strategic advantage in delivering quality, efficiency, compliance, and value.
Attendees will leave with a practical blueprint to assess whether their PV model is truly fit for purpose—or fit by compromise.